French health authorities have suspended the use of Valneva’s chikungunya vaccine Ixchiq in adults aged 65 and older after ...

Shares of French speciality vaccines developer Valneva (Nasdaq: VAL) were down 8.4% at 2.89 euros by early afternoon, after ...

Shares in Valneva plunged after the company said France's health authorities suspended the use of its chikungunya vaccine, Ixchiq, for people aged 65 and older, raising concerns about the vaccine's ...

As safety flags hang over Valneva’s chikungunya vaccine in the U.S. and beyond, French authorities are clamping down on the shot’s use in older adults. | France’s public health agency has temporarily ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that France’s national public health agency, the Haute Autorité de Santé (HAS), has updated its ...

Valneva said it has been supplying Ixchiq to help the French government respond to a major outbreak of chikungunya in La ...

Valneva has been responding to the French government's call for vaccine supply of IXCHIQ ® in La Reunion 1 as the island is going through a major chikungunya outbreak with ~ 40,000 confirmed ...

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...